B Raf (BRAF) (NM_004333) Mutant (V600E) Human Recombinant Protein
CAT:
882-PH33000M5
Size:
20 µg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


B Raf (BRAF) (NM_004333) Mutant (V600E) Human Recombinant Protein
Background:
This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]Synonyms:
B-raf; B-RAF1; BRAF1; NS7; RAFB1Gene ID:
673UniProt:
P15056Accession Number mRNA:
NM_004333Chromosomal Location:
7q34Expression System:
HEK293Tag:
C-Myc/DDKRelated Pathways:
Acute myeloid leukemia, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Focal adhesion, Glioma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, Thyroid cancer, Vascular smooth muscle contractionField of Research:
Acute myeloid leukemia, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Focal adhesion, Glioma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, Thyroid cancer, Vascular smooth muscle contractionConcentration:
>50 ug/mL as determined by microplate BCA methodPurity:
> 80% as determined by SDS-PAGE and Coomassie blue stainingActivity:
26814611Form:
LiquidBuffer:
25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerolFunction:
Druggable Genome, Protein KinaseMolecular Weight:
84 kDaStorage Conditions:
Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.Symbol:
BRAFSpecies:
HumanProtein ID:
NP_004324Overview:
Recombinant protein of human v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutant, expressed in human cellsGene ID URL:
https://www.ncbi.nlm.nih.gov/gene/673Uniprot URL:
https://www.uniprot.org/uniprot/P15056Accession Number mRNA URL:
https://www.ncbi.nlm.nih.gov/nuccore/NM_004333Protein ID Link:
https://www.ncbi.nlm.nih.gov/nuccore/NP_004324